The cutting-edge progress of immune-checkpoint blockade in lung cancer von Zhou, Fei, Qiao, Meng, Zhou, Caicun

Volltext

Non‐small cell lung cancer in China von Chen, Peixin, Liu, Yunhuan, Wen, Yaokai, Zhou, Caicun

Volltext

Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients von Yang, Zhe, Yang, Nong, Ou, Qiuxiang, Xiang, Yi, Jiang, Tao, Wu, Xue, Bao, Hua, Tong, Xiaoling, Wang, Xiaonan, Shao, Yang W, Liu, Yunpeng, Wang, Yan, Zhou, Caicun

Volltext

Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer von Wu, Fengying, Fan, Jue, He, Yayi, Xiong, Anwen, Yu, Jia, Li, Yixin, Zhang, Yan, Zhao, Wencheng, Zhou, Fei, Li, Wei, Zhang, Jie, Zhang, Xiaosheng, Qiao, Meng, Gao, Guanghui, Chen, Shanhao, Chen, Xiaoxia, Li, Xuefei, Hou, Likun, Wu, Chunyan, Su, Chunxia, Ren, Shengxiang, Odenthal, Margarete, Buettner, Reinhard, Fang, Nan, Zhou, Caicun

Volltext

Long non-coding RNA UCA1 promotes lung cancer cell proliferation and migration via microRNA-193a/HMGB1 axis von Wu, Hongyu, Zhou, Caicun

Volltext

Lung cancer in never smokers—the East Asian experience von Zhou, Fei, Zhou, Caicun

Volltext

Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer von Gong, Xiaomei, Li, Xuefei, Jiang, Tao, Xie, Huikang, Zhu, Zhengfei, Zhou, Fei, Zhou, Caicun

Volltext

Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer von He, Yayi, Rivard, Christopher J., Rozeboom, Leslie, Yu, Hui, Ellison, Kim, Kowalewski, Ashley, Zhou, Caicun, Hirsch, Fred R.

Volltext

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12) von Zhou, Caicun, Wu, Lin, Fan, Yun, Wang, Zhehai, Liu, Lianke, Chen, Gongyan, Zhang, Li, Huang, Dingzhi, Cang, Shundong, Yang, Zhixiong, Zhou, Jianying, Zhou, Chengzhi, Li, Baolan, Li, Juan, Fan, Min, Cui, Jiuwei, Li, Yuping, Zhao, Hui, Fang, Jian, Xue, Jianxin, Hu, Chengping, Sun, Ping, Du, Yingying, Zhou, Hui, Wang, Shuyan, Zhang, Wen

Volltext

cGAS-STING, an important pathway in cancer immunotherapy von Jiang, Minlin, Chen, Peixin, Wang, Lei, Li, Wei, Chen, Bin, Liu, Yu, Wang, Hao, Zhao, Sha, Ye, Lingyun, He, Yayi, Zhou, Caicun

Volltext

Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC: Dusk or Dawn? von Qiao, Meng, Jiang, Tao, Liu, Xinyu, Mao, Shiqi, Zhou, Fei, Li, Xuefei, Zhao, Chao, Chen, Xiaoxia, Su, Chunxia, Ren, Shengxiang, Zhou, Caicun

Volltext

Pan-cancer analysis of ARID1A Alterations as Biomarkers for Immunotherapy Outcomes von Jiang, Tao, Chen, Xiaoxia, Su, Chunxia, Ren, Shengxiang, Zhou, Caicun

Volltext

Role of circulating-tumor DNA analysis in non-small cell lung cancer von Jiang, Tao, Ren, Shengxiang, Zhou, Caicun

Volltext

Pyrotinib in HER2-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study von Zhou, Caicun, Li, Xingya, Wang, Qiming, Gao, Guanghui, Zhang, Yiping, Chen, Jianhua, Shu, Yongqian, Hu, Yanping, Fan, Yun, Fang, Jian, Chen, Gongyan, Zhao, Jun, He, Jianxing, Wu, Fengying, Zou, Jianjun, Zhu, Xiaoyu, Lin, Xiang

Volltext

Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy von Jiang, Minlin, Jia, Keyi, Wang, Lei, Li, Wei, Chen, Bin, Liu, Yu, Wang, Hao, Zhao, Sha, He, Yayi, Zhou, Caicun

Volltext

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and L... von Yang, James C-H, Prof, Sequist, Lecia V, MD, Geater, Sarayut Lucien, MD, Tsai, Chun-Ming, Prof, Mok, Tony Shu Kam, Prof, Schuler, Martin, Prof, Yamamoto, Nobuyuki, Prof, Yu, Chong-Jen, Prof, Ou, Sai-Hong I, MD, Zhou, Caicun, Prof, Massey, Daniel, MSc, Zazulina, Victoria, MD, Wu, Yi-Long, Prof

Volltext

EGFR‐targeted therapy alters the tumor microenvironment in EGFR‐driven lung tumors: Implications for combination therapies von Jia, Yijun, Li, Xuefei, Jiang, Tao, Zhao, Sha, Zhao, Chao, Zhang, Limin, Liu, Xiaozhen, Shi, Jinpeng, Qiao, Meng, Luo, Jiawei, Liu, Sangtian, Han, Ruoshuang, Su, Chunxia, Ren, Shengxiang, Zhou, Caicun

Volltext

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label... von Wu, Yi-Long, Prof, Zhou, Caicun, Prof, Hu, Cheng-Ping, Prof, Feng, Jifeng, Prof, Lu, Shun, Prof, Huang, Yunchao, Prof, Li, Wei, Prof, Hou, Mei, Prof, Shi, Jian Hua, Prof, Lee, Kye Young, Prof, Xu, Chong-Rui, MD, Massey, Dan, MSc, Kim, Miyoung, MD, Shi, Yang, MD, Geater, Sarayut L, MD

Volltext

Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China von Xiong, Anwen, Wang, Jiali, Zhou, Caicun

Volltext

Targeting ferroptosis for cancer therapy: exploring novel strategies from its mechanisms and role in cancers von Jiang, Minlin, Qiao, Meng, Zhao, Chuanliang, Deng, Juan, Li, Xuefei, Zhou, Caicun

Volltext